Multichannel lung sound analysis to detect severity of lung disease in cystic fibrosis

被引:6
|
作者
Karimizadeh, Arezoo [1 ]
Vali, Mansour [1 ]
Modaresi, Mohammadreza [2 ,3 ]
机构
[1] KN Toosi Univ Technol, Fac Elect Engn, Shariati Ave, Tehran 163171419, Iran
[2] Univ Tehran Med Sci, Growth & Dev Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Pediat Pulm Dis & Sleep Med Res Ctr, Pediat Ctr Excellence, Childrens Med Ctr, Tehran, Iran
关键词
Artificial neural network; Cystic fibrosis; Frequency features; Lung sounds; Support vector machine; Spirometry; PULMONARY EXACERBATIONS; BREATH SOUND; CHILDREN; ASTHMA; CLASSIFICATION; SIGNS;
D O I
10.1016/j.bspc.2020.102266
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: Respiratory disease in Cystic fibrosis (CF) patients is one of the main causes of the reduction in pulmonary function and death. The primary goals of CF treatment include maintaining or improving pulmonary function and reducing the rate of pulmonary function decline. Therefore, the severity of lung disease should be monitored in CF patients. The objective of this study is to examine multichannel lung sound analysis in detecting the severity of lung disease in CF patients. Methods: 209 multichannel lung sound samples were recorded from thirty seven CF patients using a thirty channel acquisition system. Then, expiration to inspiration lung sound power ratio features in different frequency bands (E/I F) were extracted from large airway, upper airway and peripheral airway channels. These features were compared between the groups with different severity levels of the lung disease using Support Vector Machine, Artificial Neural Network, Decision tree and Naive Baysian classifiers by 'leave-one-sample-out' method. Results: It was shown that features of upper airways and peripheral airways were more effective in discriminating normal from mild (91.1%) and moderate from severe (92.8%) respiratory sound samples, respectively. The best result for discriminating between all groups of severity was related to neural network classifier which performs 89.05% average accuracy. Also, 'leave-one-subject-out' method confirmed the results. Conclusion: The proposed multichannel lung sound analysis method was successful in discriminating different severity levels of CF lung disease. Moreover, analysis of different lung region signals in consecutive levels of lung disease was consistent with regional damage of lung in CF.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Laboratory biomarkers for lung disease severity and progression in cystic fibrosis
    Bene, Zsolt
    Fejes, Zsolt
    Macek, Milan, Jr.
    Amaral, Margarida D.
    Balogh, Istvan
    Nagy, Bela, Jr.
    CLINICA CHIMICA ACTA, 2020, 508 : 277 - 286
  • [2] Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity
    Sagel, Scott D.
    Wagner, Brandie D.
    Ziady, Assem
    Kelley, Tom
    Clancy, John P.
    Narvaez-Rivas, Monica
    Pilewski, Joseph
    Joseloff, Elizabeth
    Sha, Wei
    Zelnick, Leila
    Setchell, Kenneth D. R.
    Heltshe, Sonya L.
    Muhlebach, Marianne S.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (04) : 632 - 640
  • [3] A multimodal approach to detect and monitor early lung disease in cystic fibrosis
    Mondejar-Lopez, Pedro
    Horsley, Alexander
    Ratjen, Felix
    Bertolo, Silvia
    de Vicente, Helene
    Asensio de la Cruz, Oscar
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (06) : 761 - 772
  • [4] Validating chest MRI to detect and monitor cystic fibrosis lung disease in a pediatric cohort
    Tepper, Leonie A.
    Ciet, Pierluigi
    Caudri, Daan
    Quittner, Alexandra L.
    Utens, Elisabeth M. W. J.
    Tiddens, Har A. W. M.
    PEDIATRIC PULMONOLOGY, 2016, 51 (01) : 34 - 41
  • [5] Genetic Modifiers of Cystic Fibrosis Lung Disease Severity
    Zhou, Yi-Hui
    Gallins, Paul J.
    Pace, Rhonda G.
    Dang, Hong
    Aksit, Melis A.
    Blue, Elizabeth E.
    Buckingham, Kati J.
    Collaco, Joseph M.
    Faino, Anna V.
    Gordon, William W.
    Hetrick, Kurt N.
    Ling, Hua
    Liu, Weifang
    Onchiri, Frankline M.
    Pagel, Kymberleigh
    Pugh, Elizabeth W.
    Raraigh, Karen S.
    Rosenfeld, Margaret
    Sun, Quan
    Wen, Jia
    Li, Yun
    Corvol, Harriet
    Strug, Lisa J.
    Bamshad, Michael J.
    Blackman, Scott M.
    Cutting, Garry R.
    Gibson, Ronald L.
    O'Neal, Wanda K.
    Wright, Fred A.
    Knowles, Michael R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (10) : 1324 - 1333
  • [6] Physiological markers of exercise capacity and lung disease severity in cystic fibrosis
    Smith, Laurie
    Reilly, Charles C.
    MacBean, Victoria
    Jolley, Caroline J.
    Elston, Caroline
    Moxham, John
    Rafferty, Gerrard F.
    RESPIROLOGY, 2017, 22 (04) : 714 - 720
  • [7] The relationship between lung disease severity and the sputum proteome in cystic fibrosis
    Maher, Rosemary E.
    Barrett, Emma
    Beynon, Robert J.
    Harman, Victoria M.
    Jones, Andrew M.
    McNamara, Paul S.
    Smith, Jaclyn A.
    Lord, Robert W.
    RESPIRATORY MEDICINE, 2022, 204
  • [8] Volumetric capnography as a tool to detect early peripheric lung obstruction in cystic fibrosis patients
    Ribeiro, Maria Angela G. O.
    Silva, Marcos T. N.
    Ribeiro, Jose Dirceu
    Moreira, Marcos M.
    Almeida, Celize C. B.
    Almeida-Junior, Armando A.
    Ribeiro, Antonio F.
    Pereira, Monica C.
    Hessel, Gabriel
    Paschoal, Ilma A.
    JORNAL DE PEDIATRIA, 2012, 88 (06) : 509 - 517
  • [9] Cystic Fibrosis Lung Disease: An Overview
    Turcios, Nelson L.
    RESPIRATORY CARE, 2020, 65 (02) : 233 - 251
  • [10] DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
    Magalhaes, Milena
    Rivals, Isabelle
    Claustres, Mireille
    Varilh, Jessica
    Thomasset, Melodie
    Bergougnoux, Anne
    Mely, Laurent
    Leroy, Sylvie
    Corvol, Harriet
    Guillot, Loic
    Murris, Marlene
    Beyne, Emmanuelle
    Caimmi, Davide
    Vachier, Isabelle
    Chiron, Raphael
    De Sario, Albertina
    CLINICAL EPIGENETICS, 2017, 9